Global Registry for Endovascular Aortic Treatment (GREAT)
Description
Brief Summary
This is an observational Registry designed to obtain early data on the use of the GORE®
EXCLUDER® AAA Endoprosthesis with C3 Delivery System.
Detailed Description
This is a retrospective and prospective observational cohort Registry designed to obtain data
on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System. Patient and
device performance outcomes will be collected during treatment and throughout all
post-treatment visits, including follow-up extending up to 10 years.
Phase
N/AInclusion and Exclusion Criteria
- Inclusion Criteria:
- Minimum age required by local regulations (as applicable)
- Indication for aortic endovascular stent graft repair as determined by the treating physician (refer to current Instructions for Use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System)
Sites
Please contact Valentina Rodina to learn more about where you can participate in this trial. Please use the contact form on the right side.